Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Vac – page 62

1 101 clinical trials in Vac, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Vac at a glance
1 101
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 101 trials in Vac

Open in trial search

Acute kidney injury

Not recruiting

Study on TIN816 for Preventing Acute Kidney Injury in Adults Undergoing Cardiac Surgery

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:TIN816
  • Sponsor:Novartis Pharma AG

Neoplasm malignant

Not recruiting

Study on the Safety of Avelumab, Lorlatinib, and Axitinib for Cancer Patients Continuing from Previous Trials

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Avelumab
  • Sponsor:Pfizer Inc.

Crohn's disease

Not recruiting

Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Acute myeloid leukaemia+10

Not recruiting

Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Diabetic retinal oedema+1

Not recruiting

Study on Aflibercept for Adults with Diabetic Macular Edema or Wet Age-Related Macular Degeneration

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Bayer AG

Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Hypercholesterolaemia

Not recruiting

Study on the Safety and Efficacy of MK-0616 for Adults with High Cholesterol

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Enlicitide Chloride
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Effectiveness and Safety of Lazertinib and Gefitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Gefitinib
  • Sponsor:Yuhan Corp.

Multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Fenebrutinib and Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Endometrial cancer

Not recruiting

Study on Durvalumab, Paclitaxel, Carboplatin, and Olaparib for Patients with Advanced or Recurrent Endometrial Cancer

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Astrazeneca AB

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Vac

What the registry says about research in the country

01 Inflammatory Bowel Disease Research

Extensive clinical trials focusing on Ulcerative Colitis and Crohn's Disease treatments, evaluating innovative therapies including zasocitinib and mirikizumab for long-term disease management.

  • Moderate to Severe UC Treatment
  • Crohn's Disease Management
  • Bowel Urgency Studies

Multiple studies examining both short-term and extended treatment outcomes for inflammatory bowel conditions.

02 Neurological Disorders

Research initiatives targeting acute ischemic stroke and migraine treatments, including studies of innovative compounds like redasemtide and atogepant.

  • Stroke Prevention
  • Acute Migraine Treatment
  • Post-Stroke Care

Focused investigations on reducing stroke risk and improving acute migraine management outcomes.

03 Therapeutic Innovations

Development of novel treatments including biosimilar studies and evaluation of new molecular entities for chronic inflammatory conditions.

  • Biosimilar Development
  • Long-term Safety Studies
  • Clinical Remission Research

Comprehensive assessment of treatment efficacy and safety profiles across multiple therapeutic areas.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.